BCRX vs KMI · rev $374.7M vs P/E 24, rev $9.30B
BioCryst Pharmaceuticals Inc (BCRX) versus Kinder Morgan Inc (KMI) — a side-by-side from cached financials, not a winner call.
BioCryst Pharmaceuticals Inc (BCRX) is a drug manufacturers - specialty & generic company listed on US.
Kinder Morgan Inc (KMI) is a oil & gas midstream company listed on US.
Latest reported BCRX revenue for 2026-06-30 was $374.7M. Net income was -$643.4M. BCRX currently screens at market cap $1.83B.
Latest reported KMI revenue for 2026-06-30 was $9.30B. Net income was $1.84B. Revenue was up 92.7% from 2026-03-31 to 2026-06-30. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
BCRX currently screens at market cap $1.83B. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
Not investment advice. Open the BCRX and KMI stock pages for the full models.
Not investment advice.